- Home
- NSTS vs XGN Comparison
NSTS vs XGN Comparison
Compare NSTS & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NSTS | XGN |
|---|---|---|
| Founded | 1921 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.8M | 65.9M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NSTS | XGN |
|---|---|---|
| Price | $12.65 | $2.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $8.86 |
| AVG Volume (30 Days) | 5.7K | ★ 175.4K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $252,000.00 | N/A |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $13.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.73 | $2.59 |
| 52 Week High | $13.06 | $12.23 |
Technical Indicators
Market Signals| Indicator | NSTS | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | 43.83 |
| Support Level | $12.52 | $2.59 |
| Resistance Level | $12.74 | $3.29 |
| Average True Range (ATR) | 0.30 | 0.16 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 73.70 | 35.48 |
Price Performance
Historical ComparisonAbout NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.